Latest Drug Approvals news
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines
posted November 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Caplyta for Major Depressive Disorder in Adults
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dr. Richard Pazdur Appointed to Lead FDA”s Drug Division After Turbulent Year
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Homicide, Suicide, and Overdose Leading Causes of Maternal Death 
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Model Predicts Poor Outcomes Within 30 Days of a Before Medically Advised Discharge 
Fewer Than Half of Drug Overdose Survivors Go to the Hospital Related Articles
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations 
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children Monthly Specialist Briefings
Stay Connected
